IMVT

IMMUNOVANT INC

Healthcare | Mid Cap

-$0.72

EPS Forecast

$3.7

Revenue Forecast

Announcing earnings for the quarter ending 2025-06-30 soon
NUVBNuvation Bio IncDNAGinkgo Bioworks Holdings Inc